世界の養子細胞療法市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Adoptive Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、養子細胞療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。養子細胞療法の種類別市場規模(CAR-T、TCR-T、NK、TIL)、用途別市場規模(リンパ腫、白血病)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Novartis、Juno、Kite、Adaptimmune、Fibrocell、Lineage Cell Therapeutics、BioTime、Vericel Corporation、Regeneus、Anhui Anke Biotechnology、Cellectis、NantKwest、SorrentoTherapeutics、Bellicum
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:CAR-T、TCR-T、NK、TIL
・用途別分析2016年-2026年:リンパ腫、白血病
・養子細胞療法の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・養子細胞療法のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・養子細胞療法のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・養子細胞療法の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・養子細胞療法の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Adoptive Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Adoptive Cell Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Adoptive Cell Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Adoptive Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
CAR-T
TCR-T
NK
TIL

Market segment by Application, can be divided into
Lymphoma
Leukemia

Market segment by players, this report covers
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Adoptive Cell Therapy
1.2 Classification of Adoptive Cell Therapy by Type
1.2.1 Overview: Global Adoptive Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adoptive Cell Therapy Revenue Market Share by Type in 2020
1.2.3 CAR-T
1.2.4 TCR-T
1.2.5 NK
1.2.6 TIL
1.3 Global Adoptive Cell Therapy Market by Application
1.3.1 Overview: Global Adoptive Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Global Adoptive Cell Therapy Market Size & Forecast
1.5 Global Adoptive Cell Therapy Market Size and Forecast by Region
1.5.1 Global Adoptive Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adoptive Cell Therapy Market Size by Region, (2016-2021)
1.5.3 North America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adoptive Cell Therapy Market Drivers
1.6.2 Adoptive Cell Therapy Market Restraints
1.6.3 Adoptive Cell Therapy Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Adoptive Cell Therapy Product and Solutions
2.1.4 Novartis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Juno
2.2.1 Juno Details
2.2.2 Juno Major Business
2.2.3 Juno Adoptive Cell Therapy Product and Solutions
2.2.4 Juno Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Juno Recent Developments and Future Plans
2.3 Kite
2.3.1 Kite Details
2.3.2 Kite Major Business
2.3.3 Kite Adoptive Cell Therapy Product and Solutions
2.3.4 Kite Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kite Recent Developments and Future Plans
2.4 Adaptimmune
2.4.1 Adaptimmune Details
2.4.2 Adaptimmune Major Business
2.4.3 Adaptimmune Adoptive Cell Therapy Product and Solutions
2.4.4 Adaptimmune Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Adaptimmune Recent Developments and Future Plans
2.5 Fibrocell
2.5.1 Fibrocell Details
2.5.2 Fibrocell Major Business
2.5.3 Fibrocell Adoptive Cell Therapy Product and Solutions
2.5.4 Fibrocell Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fibrocell Recent Developments and Future Plans
2.6 Lineage Cell Therapeutics
2.6.1 Lineage Cell Therapeutics Details
2.6.2 Lineage Cell Therapeutics Major Business
2.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Product and Solutions
2.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lineage Cell Therapeutics Recent Developments and Future Plans
2.7 BioTime
2.7.1 BioTime Details
2.7.2 BioTime Major Business
2.7.3 BioTime Adoptive Cell Therapy Product and Solutions
2.7.4 BioTime Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioTime Recent Developments and Future Plans
2.8 Vericel Corporation
2.8.1 Vericel Corporation Details
2.8.2 Vericel Corporation Major Business
2.8.3 Vericel Corporation Adoptive Cell Therapy Product and Solutions
2.8.4 Vericel Corporation Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vericel Corporation Recent Developments and Future Plans
2.9 Regeneus
2.9.1 Regeneus Details
2.9.2 Regeneus Major Business
2.9.3 Regeneus Adoptive Cell Therapy Product and Solutions
2.9.4 Regeneus Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Regeneus Recent Developments and Future Plans
2.10 Anhui Anke Biotechnology
2.10.1 Anhui Anke Biotechnology Details
2.10.2 Anhui Anke Biotechnology Major Business
2.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Product and Solutions
2.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Anhui Anke Biotechnology Recent Developments and Future Plans
2.11 Cellectis
2.11.1 Cellectis Details
2.11.2 Cellectis Major Business
2.11.3 Cellectis Adoptive Cell Therapy Product and Solutions
2.11.4 Cellectis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cellectis Recent Developments and Future Plans
2.12 NantKwest
2.12.1 NantKwest Details
2.12.2 NantKwest Major Business
2.12.3 NantKwest Adoptive Cell Therapy Product and Solutions
2.12.4 NantKwest Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 NantKwest Recent Developments and Future Plans
2.13 SorrentoTherapeutics
2.13.1 SorrentoTherapeutics Details
2.13.2 SorrentoTherapeutics Major Business
2.13.3 SorrentoTherapeutics Adoptive Cell Therapy Product and Solutions
2.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 SorrentoTherapeutics Recent Developments and Future Plans
2.14 Bellicum
2.14.1 Bellicum Details
2.14.2 Bellicum Major Business
2.14.3 Bellicum Adoptive Cell Therapy Product and Solutions
2.14.4 Bellicum Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Bellicum Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adoptive Cell Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adoptive Cell Therapy Players Market Share
3.2.2 Top 10 Adoptive Cell Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Adoptive Cell Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adoptive Cell Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Adoptive Cell Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021)
5.2 Adoptive Cell Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adoptive Cell Therapy Revenue by Type (2016-2026)
6.2 North America Adoptive Cell Therapy Revenue by Application (2016-2026)
6.3 North America Adoptive Cell Therapy Market Size by Country
6.3.1 North America Adoptive Cell Therapy Revenue by Country (2016-2026)
6.3.2 United States Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adoptive Cell Therapy Revenue by Type (2016-2026)
7.2 Europe Adoptive Cell Therapy Revenue by Application (2016-2026)
7.3 Europe Adoptive Cell Therapy Market Size by Country
7.3.1 Europe Adoptive Cell Therapy Revenue by Country (2016-2026)
7.3.2 Germany Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.3 France Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adoptive Cell Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Adoptive Cell Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Adoptive Cell Therapy Revenue by Region (2016-2026)
8.3.2 China Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.5 India Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adoptive Cell Therapy Revenue by Type (2016-2026)
9.2 South America Adoptive Cell Therapy Revenue by Application (2016-2026)
9.3 South America Adoptive Cell Therapy Market Size by Country
9.3.1 South America Adoptive Cell Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adoptive Cell Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Adoptive Cell Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Adoptive Cell Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Adoptive Cell Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Novartis、Juno、Kite、Adaptimmune、Fibrocell、Lineage Cell Therapeutics、BioTime、Vericel Corporation、Regeneus、Anhui Anke Biotechnology、Cellectis、NantKwest、SorrentoTherapeutics、Bellicum

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の養子細胞療法市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Adoptive Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。